Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
Phase I study of irinotecan and raltitrexed in patients with advanced gastrointestinal tract adenocarcinoma. [electronic resource] by
- Ford, H E
- Cunningham, D
- Ross, P J
- Rao, S
- Aherne, G W
- Benepal, T S
- Price, T
- Massey, A
- Vernillet, L
- Gruia, G
Producer: 20000808
In:
British journal of cancer vol. 83
Availability: No items available.
|
|
14.
|
Subcutaneous oxyntomodulin analogue administration reduces body weight in lean and obese rodents. [electronic resource] by
- Liu, Y-L
- Ford, H E
- Druce, M R
- Minnion, J S
- Field, B C T
- Shillito, J C
- Baxter, J
- Murphy, K G
- Ghatei, M A
- Bloom, S R
Producer: 20110418
In:
International journal of obesity (2005) vol. 34
Availability: No items available.
|